![Transparency Market Researchが調査・発行した産業分析レポートです。ドライアイ疾患治療の世界市場2020-2030：製品別（人工涙液、抗炎症剤[シクロスポリン、コルチコステロイド、その他]、涙点プラグ、分泌促進薬、その他）、疾患別、流通チャンネル別 / Dry Eye Disease Treatment Market (Product: Artificial Tears, Anti-inflammatory [Cyclosporine, Corticosteroid, and Others], Punctal Plugs, Secretagogue, and Others; Disease: Evaporative Dry Eye Syndrome and Aqueous Dry Eye Syndrome; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030 / TMR2008083資料のイメージです。](https://www.marketresearch.co.jp/images-folder2/report-contents-43.gif) | • レポートコード：TMR2008083 • 出版社/出版日：Transparency Market Research / 2020年7月30日 • レポート形態：英文、PDF、214ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートではドライアイ疾患治療の世界市場について調査・分析し、序文、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別（人工涙、抗炎症薬、涙点プラグ、分泌促進物質、その他）分析、疾患別（蒸発性ドライアイ症候群、水性ドライアイ症候群）分析、流通チャンネル別（病院薬局、小売薬局、オンライン薬局）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを含め、以下の構成でご提供いたします。 ・序文 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・ドライアイ疾患治療の世界市場：製品別（人工涙、抗炎症薬、涙点プラグ、分泌促進物質、その他） ・ドライアイ疾患治療の世界市場：疾患別（蒸発性ドライアイ症候群、水性ドライアイ症候群） ・ドライアイ疾患治療の世界市場：流通チャンネル別（病院薬局、小売薬局、オンライン薬局） ・ドライアイ疾患治療の世界市場：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Dry Eye Disease Treatment Market – Scope of the Report
TMR’s report on the global dry eye disease treatment market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides revenue of the global dry eye disease treatment market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) for the global dry eye disease treatment market during the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global dry eye disease treatment market.
Secondary research also includes Internet sources, statistical data from government agencies, websites, companies’ presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global dry eye disease treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global dry eye disease treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global dry eye disease treatment market.
The report delves into the competition landscape of the global dry eye disease treatment market. Key players operating in the global dry eye disease treatment market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global dry eye disease treatment market that have been profiled in this report.
Key Questions Answered in Dry Eye Disease Treatment Market Report
What is the scope of growth of the anti-inflammatory segment of the global dry eye disease treatment market?
What will be the Y-o-Y growth of the global dry eye disease treatment market between 2020 and 2030?
What is the influence of changing trends in cyclosporine on the global dry eye disease treatment market?
Will North America continue to be the most profitable market for dry eye disease drug providers?
Which factors are anticipated to hamper the growth of the global dry eye disease treatment market during the forecast period?
Which are the leading companies in the global dry eye disease treatment market?
Research Methodology
A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global dry eye disease treatment market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the global dry eye disease treatment market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the global dry eye disease treatment market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the dry eye disease treatment market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global dry eye disease treatment market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global dry eye disease treatment market more reliably and accurately.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Dry Eye Disease Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Dry Eye Disease Treatment Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Global Dry Eye Disease Treatment Market: Key Mergers & Acquisitions
5.2. Pipeline Analysis
5.3. Disease Prevalence & Incidence Rate Globally with Key Countries
5.4. Technological Advancement
5.5. COVID-19 Pandemics Impact on Industry (Short / Mid / Long Term Impact)
6. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Dry Eye Disease Treatment Market Value Forecast, by Product, 2018–2030
6.2.1. Artificial Tears
6.2.2. Anti-inflammatory
6.2.2.1. Cyclosporine
6.2.2.2. Corticosteroid
6.2.2.3. Others
6.2.3. Punctal Plugs
6.2.4. Secretagogue
6.2.5. Others
6.3. Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Product
7. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Disease
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global Dry Eye Disease Treatment Market Value Forecast, by Disease, 2018–2030
7.2.1. Evaporative Dry Eye Syndrome
7.2.2. Aqueous Dry Eye Syndrome
7.3. Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease
8. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.1.1. Key Findings / Developments
8.2. Global Dry Eye Disease Treatment Market Value Forecast, by Distribution Channel, 2018–2030
8.2.1. Hospital Pharmacies
8.2.2. Retail Pharmacies
8.2.3. Online Pharmacies
8.3. Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel
9. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Dry Eye Disease Treatment Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Region
10. North America Dry Eye Disease Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
10.2.1. Artificial Tears
10.2.2. Anti-inflammatory
10.2.2.1. Cyclosporine
10.2.2.2. Corticosteroid
10.2.2.3. Others
10.2.3. Punctal Plugs
10.2.4. Secretagogue
10.2.5. Others
10.3. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
10.3.1. Evaporative Dry Eye Syndrome
10.3.2. Aqueous Dry Eye Syndrome
10.4. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030
10.5.1. U.S.
10.5.2. Canada
10.6. North America Dry Eye Disease Treatment Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Disease
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Dry Eye Disease Treatment Market Analysis and Forecast
11.1. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
11.1.1. Artificial Tears
11.1.2. Anti-inflammatory
11.1.2.1. Cyclosporine
11.1.2.2. Corticosteroid
11.1.2.3. Others
11.1.3. Punctal Plugs
11.1.4. Secretagogue
11.1.5. Others
11.2. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
11.2.1. Evaporative Dry Eye Syndrome
11.2.2. Aqueous Dry Eye Syndrome
11.3. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Online Pharmacies
11.4. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
11.4.1. Germany
11.4.2. U.K.
11.4.3. France
11.4.4. Spain
11.4.5. Italy
11.4.6. Rest of Europe
11.5. Europe Dry Eye Disease Treatment Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By Disease
11.5.3. By Distribution Channel
11.5.4. By Country/Sub-region
12. Asia Pacific Dry Eye Disease Treatment Market Analysis and Forecast
12.1. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
12.1.1. Artificial Tears
12.1.2. Anti-inflammatory
12.1.2.1. Cyclosporine
12.1.2.2. Corticosteroid
12.1.2.3. Others
12.1.3. Punctal Plugs
12.1.4. Secretagogue
12.1.5. Others
12.2. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
12.2.1. Evaporative Dry Eye Syndrome
12.2.2. Aqueous Dry Eye Syndrome
12.3. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
12.3.1. Hospital Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Online Pharmacies
12.4. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
12.4.1. China
12.4.2. Japan
12.4.3. India
12.4.4. Australia & New Zealand
12.4.5. Rest of Asia Pacific
12.5. Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By Disease
12.5.3. By Distribution Channel
12.5.4. By Country/Sub-region
13. Latin America Dry Eye Disease Treatment Market Analysis and Forecast
13.1. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
13.1.1. Artificial Tears
13.1.2. Anti-inflammatory
13.1.2.1. Cyclosporine
13.1.2.2. Corticosteroid
13.1.2.3. Others
13.1.3. Punctal Plugs
13.1.4. Secretagogue
13.1.5. Others
13.2. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
13.2.1. Evaporative Dry Eye Syndrome
13.2.2. Aqueous Dry Eye Syndrome
13.3. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
13.3.1. Hospital Pharmacies
13.3.2. Retail Pharmacies
13.3.3. Online Pharmacies
13.4. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Rest of Latin America Latin America
13.5. Latin America Dry Eye Disease Treatment Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By Disease
13.5.3. By Distribution Channel
13.5.4. By Country/Sub-region
14. Middle East & Africa Dry Eye Disease Treatment Market Analysis and Forecast
14.1.1.
14.2. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
14.2.1. Artificial Tears
14.2.2. Anti-inflammatory
14.2.2.1. Cyclosporine
14.2.2.2. Corticosteroid
14.2.2.3. Others
14.2.3. Punctal Plugs
14.2.4. Secretagogue
14.2.5. Others
14.3. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
14.3.1. Evaporative Dry Eye Syndrome
14.3.2. Aqueous Dry Eye Syndrome
14.4. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Disease
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region
15. Competitive Landscape
15.1. Market Player – Competition Matrix (by Tier and Size of companies)
15.2. Market Share / Position Analysis, by Company, 2018
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. Novartis AG
15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.1.2. Growth Strategies
15.4.1.3. SWOT Analysis
15.4.2. Allergan
15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.2.2. Growth Strategies
15.4.2.3. SWOT Analysis
15.4.3. Santen Pharmaceutical Co., Ltd.
15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.3.2. Growth Strategies
15.4.3.3. SWOT Analysis
15.4.4. OASIS Medical
15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.4.2. Growth Strategies
15.4.4.3. SWOT Analysis
15.4.5. Sun Pharmaceutical Industries Ltd.
15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.5.2. Growth Strategies
15.4.5.3. SWOT Analysis
15.4.6. Johnson & Johnson
15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.6.2. Growth Strategies
15.4.6.3. SWOT Analysis
15.4.7. Otsuka Pharmaceutical Co., Ltd.
15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.7.2. Growth Strategies
15.4.7.3. SWOT Analysis
15.4.8. Sentiss Pharma Pvt. Ltd.
15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.8.2. Growth Strategies
15.4.8.3. SWOT Analysis
15.4.9. RegeneRx (ReGenTree, LLC)
15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.9.2. Growth Strategies
15.4.9.3. SWOT Analysis
15.4.10. Bausch Health Companies, Inc.
15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.10.2. Growth Strategies
15.4.10.3. SWOT Analysis
List of TablesTable 1: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 2: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030
Table 3: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
Table 4: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 5: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 6: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 7: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 8: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030
Table 9: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
Table 10: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 11: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 12: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 13: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030
Table 14: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
Table 15: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 16: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 17: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 18: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030
Table 19: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
Table 20: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 21: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 22: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 23: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030
Table 24: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
Table 25: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 26: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 27: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 28: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030
Table 29: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
Table 30: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030